Transforming India’s approach to cancer care
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
Cancer
-
Manipulating the basics
How do you fix faulty genes that cause cellular havoc by sending out all the wrong signals? Using molecular genetic techniques, scientists are trying to insert bits of foreign DNA into cancerous
-
Cancer research in India
In India, medical research has concentrated on communicable diseases like tuberculosis and leprosy. Cancer research is still at a preliminary stage and most research centres have focused on the
-
Malignant squad
Cancer sneaks in through various agents. Some instances:
-
Programmed for death
Cells are not immortal. But cancer scientists have only recently taken this fact seriously. Apoptosis, a Greek word meaning the shedding of leaves in autumn, refers to the tendency of cells to commit
-
Cancer Hospital
The travails of Nepal's estimated 50,000 cancer patients may soon be at an end. Instead of going abroad for treatment, they will have access to medical treatment at the 100-bed B.P. Koirala
-
Spinach gives green signal to smokers
A diet rich in leafy vegetables and minerals can ward off cancer of the mouth, claim researchers.
-
Turmeric shields
TURMERIC -- the age-old panacea for headaches, pimples and fractured limbs -- could also keep cancer away, say scientists at the Hyderabad-based National Institute of Nutrition. Kamala
-
Falling prey to the evil weed
TOBACCO came to India in the 17th century with the Portuguese and today, the plant is grown over as much as half a million hectares in the country. India was one of the first countries in the
-
The price of life
CALCULATED in monetary terms, the benefits of plants used against cancer is estimated to be $1,100 billion. The Organisation for Economic Cooperation and Development puts the value of a human life at
-
Operation Himalayan yew
In response to the threat posed by multinational companies to the Himalayan yew (Taxus baccata), which yields the anti-cancer drug taxol, the Centre for Scientific and Industrial Research (CSIR) has